The Yale Health site has reported that a student has been diagnosed to have been suffering from serogroup B meningococcal meningitis. This is one in a long list of institutions that have been reporting outbreaks or cases of meningococcal meningitis in college students in the last few months.
The Yale Health site goes on to elucidate the problems associated with a type B outbreak ot case (as far as contacts of the case are concerned):
Connecticut state law requires that students in residential settings be vaccinated against meningococcal disease, but the vaccine that most of our students receive does not protect against serogroup B meningococcal disease. There is, however, a newer form of vaccine that does cover serogroup B. With a single case on campus, federal, state, and local health officials do not recommend mass vaccinations, but we are prepared to offer the new vaccine to anyone in the Yale community who wishes to be vaccinated.
It will be interesting to note how this infectious outbreak across the student population is controlled and whether any indication can be had why this year there have been so many outbreaks across non-contiguous campuses of different universities across the United States.